Latest filing published 01 Nov 2016 for Cellectar Biosciences, Inc., €39k.
Insider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -57.3%Entry US$11,460.00 · Close at T+365 US$4,890.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Richard Hertzberg: trading record in brief
All filings by Richard Hertzberg on record concern Cellectar Biosciences, Inc. Over a trading history stretching from 15 April 2016 to 31 October 2016, the count stands at 3 filings.
Both buying and selling appear: 2 purchases worth €448k, against 1 sale worth €39k. Netting one side against the other leaves €409k of net buying. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 1 November 2016 with an open-market sale (€39k) in Cellectar Biosciences, Inc. The latest purchase dates back some time: it was published 3,800 days ago, on 14 June 2016. The median gap between a trade and its publication by SEC (Form 4) is 54 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Richard Hertzberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 21,000 shares@ US$2.038.0% of flowCellectar Biosciences, Inc. common stock (CLRB)SEC:0001676051-16-000006:0
- 234,742 shares@ US$2.1290.7% of flowCellectar Biosciences, Inc. (CLRB) Common StockSEC:0001676051-16-000004:0Canonical exit: 14 Jul 2016 (T+90)
- 3,758 shares@ US$1.901.3% of flowCellectar Biosciences, Inc.SEC:0001676051-16-000004:1Canonical exit: 20 Jul 2016 (T+90)
3 of 3 declarations
